Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Janux Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +1 vs. Q3 2021
- Shares held
- 27.5M
- +997.8K (+3.8%) vs. Q3 2021
- Total value
- $541.6M
- −$29.6M (−5.2%) vs. Q3 2021
- New holders
- 6
- 19 more added
- Sold out
- 5
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,670,644 | $171.1M | 3.02% | 00.0% | Unchanged |
| FMR LLC | 4,991,402 | $98.5M | 0.01% | +1,375,971+38.1% | Added |
| OrbiMed Advisors LLC | 2,836,386 | $56.0M | 0.73% | −630,000−18.2% | Reduced |
| Janus Henderson Group PLC | 2,400,893 | $46.6M | 0.02% | −15,511−0.6% | Reduced |
| Citadel Advisors LLC | 1,853,432 | $36.6M | 0.04% | −5,814−0.3% | Reduced |
| EcoR1 Capital, LLC | 1,411,975 | $27.9M | 0.89% | 00.0% | Unchanged |
| BVF Inc | 1,017,314 | $20.1M | 0.73% | 00.0% | Unchanged |
| BlackRock Inc. | 1,008,261 | $19.9M | 0.00% | +206,483+25.8% | Added |
| Vanguard Group Inc | 533,071 | $10.5M | 0.00% | +2,829+0.5% | Added |
| 5AM Venture Management, LLC | 446,266 | $8.80M | 1.65% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 411,871 | $8.13M | 1.62% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 400,000 | $7.89M | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 278,275 | $5.49M | 0.08% | −21,756−7.3% | Reduced |
| Geode Capital Management, LLC | 220,527 | $4.35M | 0.00% | +8,647+4.1% | Added |
| State Street Corp | 211,566 | $4.17M | 0.00% | +36,922+21.1% | Added |
| Logos Global Management LP | 185,196 | $3.65M | 0.38% | −61,926−25.1% | Reduced |
| Cerity Partners LLC | 150,933 | $2.98M | 0.05% | +150,933 | New |
| Northern Trust Corp | 115,495 | $2.28M | 0.00% | −1,466−1.3% | Reduced |
| DekaBank Deutsche Girozentrale | 45,000 | $892.0K | 0.00% | +45,000 | New |
| Bank of New York Mellon Corp | 36,537 | $721.0K | 0.00% | +5,064+16.1% | Added |
| Charles Schwab Investment Management Inc | 33,946 | $670.0K | 0.00% | +1,370+4.2% | Added |
| Parkwood LLC | 32,128 | $634.0K | 0.11% | +11,351+54.6% | Added |
| D. E. Shaw & Co., Inc. | 27,771 | $548.0K | 0.00% | −18,385−39.8% | Reduced |
| Nuveen Asset Management, LLC | 19,457 | $345.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,746 | $311.0K | 0.00% | +15,746 | New |
| Goldman Sachs Group Inc | 14,748 | $291.0K | 0.00% | +14,748 | New |
| Morgan Stanley | 14,479 | $285.0K | 0.00% | +7,777+116.0% | Added |
| JPMorgan Chase & Co | 13,288 | $262.0K | 0.00% | +6,814+105.3% | Added |
| Rhumbline Advisers | 11,037 | $218.0K | 0.00% | −73−0.7% | Reduced |
| Chicago Partners Investment Group LLC | 11,380 | $188.0K | 0.01% | +1,922+20.3% | Added |
| New York State Common Retirement Fund | 9,521 | $188.0K | 0.00% | +7,221+314.0% | Added |
| Deutsche Bank AG | 8,618 | $170.0K | 0.00% | +433+5.3% | Added |
| Wells Fargo & Company | 8,223 | $163.0K | 0.00% | +8,149+11,012.2% | Added |
| Bank of America Corp | 7,634 | $150.0K | 0.00% | +4,691+159.4% | Added |
| California State Teachers Retirement System | 7,149 | $141.0K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 7,031 | $139.0K | 0.00% | −211−2.9% | Reduced |
| Allspring Global Investments Holdings, LLC | 5,357 | $105.0K | 0.00% | +5,357 | New |
| MetLife Investment Management | 5,302 | $104.6K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,784 | $94.0K | 0.00% | +3,029+172.6% | Added |
| Metropolitan Life Insurance Co | 4,011 | $79.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,685 | $73.0K | 0.00% | +185+5.3% | Added |
| Royal Bank of Canada | 2,952 | $58.0K | 0.00% | +115+4.1% | Added |
| Tower Research Capital LLC (TRC) | 1,384 | $27.0K | 0.00% | +862+165.1% | Added |
| Legal & General Group Plc | 1,239 | $24.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,014 | $20.0K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 121 | $2.00K | 0.00% | +121 | New |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −65,414−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −59,366−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −40,860−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −124−100.0% | Sold out |